Skip to Main content Skip to Navigation
Journal articles

State of art and limitations in genetic engineering to induce stable chondrogenic phenotype

Abstract : Current protocols for chondrocyte expansion and chondrogenic differentiation of stem cells fail to reduce phenotypic loss and to mitigate hypertrophic tendency. To this end, cell genetic manipulation is gaining pace as a means of generating cells with stable chondrocyte phenotype. Herein, we provide an overview of candidate genes that either induce cartilage regeneration or inhibit cartilage degeneration. We further discuss in vitro, ex vivo and in vivo viral transduction and non-viral transfection strategies for targeted cells (chondrocytes, me-senchymal stem cells, induced pluripotent stem cells and synovial cells), along with the most representative results obtained in pre-clinical models and in clinical trials. We highlight current challenges and associated risks that slowdown clinical acceptance and commercialisation of gene transfer technologies.
Complete list of metadata
Contributor : Arnaud Eyraud Connect in order to contact the contributor
Submitted on : Tuesday, July 24, 2018 - 2:13:56 PM
Last modification on : Wednesday, April 27, 2022 - 4:34:33 AM
Long-term archiving on: : Thursday, October 25, 2018 - 3:34:59 PM


 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamais

Please log in to resquest access to the document



Valeria Graceffa, Claire Vinatier, Jérôme Guicheux, Christopher J. Evans, Martin Stoddart, et al.. State of art and limitations in genetic engineering to induce stable chondrogenic phenotype. Biotechnology Advances, Elsevier, 2018, ⟨10.1016/j.biotechadv.2018.07.004⟩. ⟨inserm-01848216⟩



Record views